The rules of pharma supplier selection have changed — is your strategy keeping up?
The way pharma companies choose their suppliers has fundamentally shifted and it’s essentially to understanding them all. Decision-making has become longer, more collaborative, and far more rigorous, with larger cross-functional teams and formal procurement processes now the norm rather than the exception. Cost is no longer the primary motivator. Today’s buyers are conducting more extensive research than ever before when evaluating new partners.
For marketing teams, this represents both a challenge and an opportunity. Suppliers that invest in brand awareness, thought leadership, and trusted industry presence are best positioned to influence an increasingly discerning buyer. This white paper delivers the data and insights to refine messaging, reach the right stakeholders, and win business in a very competitive landscape.
Download